Skip to main content

Table 2 Summary of the available data about recurrence patterns and survival outcomes

From: Laparoscopic versus open resection for gastric gastrointestinal stromal tumors: an updated systematic review and meta-analysis

Case Group Risk Recurrence Survival Case Group Risk Recurrence Survival Case Group Risk Recurrence Survival
[21] LAP High NR Dead [26] OPEN NR NR Dead [31] OPEN High 6 m Liver 52 m Alivea
[21] OPEN High NR 14 m Dead [27] OPEN High Local Deadb [31] OPEN High 9 m Liver 75 m Alivea
[22] LAP High Liver 32 m Dead [27] OPEN High Local Alivea [31] OPEN High 21 m Liver 16y Deada
[22] OPEN High Liver 9 m Dead [27] OPEN High Liver Alivea [36] OPEN High 52 m Peritoneal Deada
[22] LAP Low Local Alive [27] OPEN High Multiple Alivea [36] OPEN High 60 m Liver Alive
[24] LAP Low 33 m Local Alive [29] LAP High Peritoneal 4 y Alive [36] OPEN High 6 m Colon Deada
[24] OPEN High 7 m Peritoneal Alive [29] OPEN Moderate Liver 10 y Alive [36] LAP High 31 m Stomach Alive
[24] OPEN High 53 m Local Alive [31] OPEN High 4 m Liver 28 m Deada [36] OPEN High 15 Peritoneal Deada
[24] OPEN High 37 m Liver Alive [31] OPEN High 10 m Liver Alivea [39] OPEN High 11 m Liver 59 m Alive
[24] OPEN High 15 m Multipled Alive [31] OPEN High 42 m Liver 46 m Deada,c      
  1. LAP, laparoscopic surgery; m: month; NR, not reported; OPEN, open surgery; y: year.
  2. atreated with imatinib; bdue to cardiac insufficiency; cdue to lung cancer; dincluded liver and local recurrence.